218 related articles for article (PubMed ID: 34270885)
1. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
Hughes JH; Keizer RJ
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
[TBL] [Abstract][Full Text] [Related]
2. Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.
Hughes JH; Tong DMH; Lucas SS; Faldasz JD; Goswami S; Keizer RJ
Clin Pharmacol Ther; 2021 Jan; 109(1):233-242. PubMed ID: 33068298
[TBL] [Abstract][Full Text] [Related]
3. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
5. Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach.
Claisse G; Zufferey PJ; Trone JC; Maillard N; Delavenne X; Laporte S; Ollier E
Br J Clin Pharmacol; 2019 Jun; 85(6):1215-1226. PubMed ID: 30768726
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
[TBL] [Abstract][Full Text] [Related]
8. Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr.
Le Louedec F; Puisset F; Thomas F; Chatelut É; White-Koning M
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1208-1220. PubMed ID: 34342170
[TBL] [Abstract][Full Text] [Related]
9. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
[TBL] [Abstract][Full Text] [Related]
10. Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.
van der Meer AF; Touw DJ; Marcus MA; Neef C; Proost JH
Ther Drug Monit; 2012 Oct; 34(5):526-34. PubMed ID: 22846895
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
13. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
[TBL] [Abstract][Full Text] [Related]
14. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
[TBL] [Abstract][Full Text] [Related]
15. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
16. To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Goutelle S; Alloux C; Bourguignon L; Van Guilder M; Neely M; Maire P
Ther Drug Monit; 2021 Aug; 43(4):461-471. PubMed ID: 34250963
[TBL] [Abstract][Full Text] [Related]
17. A machine learning approach to predict daptomycin exposure from two concentrations based on Monte Carlo simulations.
Codde C; Rivals F; Destere A; Fromage Y; Labriffe M; Marquet P; Benoist C; Ponthier L; Faucher J-F; Woillard J-B
Antimicrob Agents Chemother; 2024 May; 68(5):e0141523. PubMed ID: 38501807
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
[TBL] [Abstract][Full Text] [Related]
19. Relationships of Vancomycin Pharmacokinetics to Body Size and Composition Using a Novel Pharmacomorphomic Approach Based on Medical Imaging.
Pai MP; Derstine BA; Lichty M; Ross BE; Sullivan JA; Su GL; Wang SC
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807918
[TBL] [Abstract][Full Text] [Related]
20. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
